Defining mechanisms of cardiomyocyte proliferation should guide the understanding of endogenous cardiac regeneration and could lead to novel treatments for diseases such as myocardial infarction. In the neonatal heart, energy metabolic reprogramming (phenotypic alteration of glucose, fatty acid, and amino acid metabolism) parallels cell cycle arrest of cardiomyocytes. The metabolic reprogramming occurring shortly after birth is associated with alterations in blood oxygen levels, metabolic substrate availability, hemodynamic stress, and hormone release. In the adult heart, myocardial infarction causes metabolic reprogramming but these changes cannot stimulate sufficient cardiomyocyte proliferation to replace those lost by the ischemic injury. Some putative pro-proliferative interventions can induce the metabolic reprogramming. Recent data show that altering the metabolic enzymes PKM2 [pyruvate kinase 2], LDHA [lactate dehydrogenase A], PDK4 [pyruvate dehydrogenase kinase 4], SDH [succinate dehydrogenase], CPT1b [carnitine palmitoyl transferase 1b], or HMGCS2 [3-hydroxy-3-methylglutaryl-CoA synthase 2] is sufficient to partially reverse metabolic reprogramming and promotes adult cardiomyocyte proliferation. How metabolic reprogramming regulates cardiomyocyte proliferation is not clearly defined. The possible mechanisms involve biosynthetic pathways from the glycolysis shunts and the epigenetic regulation induced by metabolic intermediates. Metabolic manipulation could represent a new approach to stimulate cardiac regeneration; however, the efficacy of these manipulations requires optimization, and novel molecular targets need to be defined. In this review, we summarize the features, triggers, and molecular regulatory networks responsible for metabolic reprogramming and discuss the current understanding of metabolic reprogramming as a critical determinant of cardiomyocyte proliferation.
Objectives: To assess the aorta elastic properties in the procession of atherosclerosis by ultra-high frequency ultrasound, and to detect whether there was a relationship between the aorta elastic properties and the severity of atherosclerotic plaque. Methods: Mice deficient for the ApoE with high-cholestrol diet (Apo E−/−) were studied as an age-dependent model of atherosclerosis. At 10, 20, 30 and 40 weeks of age, the blood pressure in the ascending aorta was measured by catheter, and the aorta mechanical properties were assessed by measuring aortic elastic modulus and pulse transit time of the ascending aorta with ultrahigh frequency ultrasound. The plaque burden was assessed by high-frequency ultrasound and Masson’s trichrome stain, separately. Results: Elastic modulus of the aorta (EAo) significantly increased from 10 to 40 wks of age, and there was also an age-dependent decrease in PTT in Apo E−/− mice. Vessel thickness at the lesion-prone sites of the lesser curvature of the aorta and the proximal brachiocephalic artery increased with age, consistent with the Masson’s trichrome staining which showed age-dependent worsening of atherosclerosis in the mice model. There was a statistically relationship between the aorta mechanical properties and the severity of plaque. Conclusions: With the progression of atherosclerosis and the increased plaque burden, aorta mechanical properties deteriorated in Apo E−/− mice. Ultra-high ultrasound was a potential tool for assessment of plaque burden and aorta mechanical properties in mouse model.
Introduction: Genetic variants in the Tenascin-XB (TNXB) gene have been associated with autosomal recessive Ehlers-Danlos Syndrome (classical-like) without vascular features. Here, we report the contribution of two TNXB variants, in cis or trans, to the development of arterial aneurysms and bicuspid aortic valves with or without connective tissue disease features present. Methods: The identification of compound heterozygosity in TNXB (c.8791+1G>A, c.12469+2T>C) in a 52-year-old female with fibromuscular dysplasia, bilateral vertebral artery dissections, and thoracic aortic aneurysm by whole exome sequencing (WES) prompted screening for TNXB variants in an institutional WES registry comprising 350 individuals with aneurysms and/or dissections. Multigene panel testing (MGPT) results from 1844 individuals tested at Ambry Genetics for a personal or family history of aneurysms, dissections, or other connective tissue disease features were used for replication analysis. Random exomes of 26,922 unaffected individuals were used as controls. Statistical analysis using Fisher’s exact test was carried out to compare the frequency of two or more TNXB variants in cases vs. controls. AlphaFold3 structural modeling was used to assess the effects of variants in cis on the 3-D structure and molecular interaction with the TGF-beta-3 proprotein. Results: There were significantly higher numbers of individuals who carried two or more rare, nonsynonymous TNXB variants, in cis or trans, in both WES (n=5/350; 1.4%) and MGPT (n=19/1844, 1.0%) datasets (p<0.01) compared to ethnically matched controls (n=89/26922; 0.14%). Additionally, there was a significantly higher prevalence of bicuspid aortic valve (BAV) in the MGPT cohort compared to the general population (11% vs. <2 % reported). The analysis by AlphaFold3 structural modeling revealed increased distortion of the 3-D structure caused by the presence of two variant(s) in cis vs. one variant in TNXB. Conclusion: This data strongly suggests an association between vascular aneurysm and/or dissection or bicuspid aortic valves and individuals with two TNXB variants.